Hungary's Competition Office (GVH) has exercised its leniency policy and exempted German drugmaker Bayer from a resolution in a case involving Belgium's Ferro, because it provided the office with information about the matter, the office announced. GVH cited unfair practise on Hungary's butylbenzylphthalate (BBP) market between August 2000 and July 2002 when levying a Ft 8 mln fine on Ferro. The office cited "insignificant" turnover on the market when explaining the relatively small size of the fine. GVH reduced the fine for Ferro 30% because the company cooperated with the office.
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.